T Cell News and Research

Latest T Cell News and Research

Gynaecological cancer still remains a taboo subject

They're thrown into menopause in their twenties, lose the possibility to have biological children, and struggle with their sex life.

18 Sep 2015

Specific biomarker predicts which HER2-negative breast cancer patients respond to targeted therapy

A multicenter team led by Case Western Reserve has demonstrated that brief exposure to a targeted therapy can tell doctors which HER2-negative patients will respond — and which should switch to another kind of treatment.

18 Sep 2015

Tolerability benefits with sunitinib schedule switch

Switching sunitinib treatment from a 4/2 to a modified 2/1 schedule can improve the tolerability profile for patients with metastatic renal cell carcinoma, say researchers.

17 Sep 2015

First-line TKI adverse event profile has no bearing on second-line RCC treatment choice

In metastatic renal cell carcinoma patients, there is no significant correlation between adverse event profiles of first- and second-line tyrosine kinase inhibitors, suggests a Japanese study.

17 Sep 2015

Active surveillance ‘viable option’ for SRM management

US researchers find no significant difference in survival outcomes between patients with small renal masses who opt for active surveillance and those who choose immediate treatment.

17 Sep 2015

Sphere Medical publishes white paper on blood conservation in critical care

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, has published a white paper exploring the issues in critical care around anaemia, transfusions and blood conservation. Entitled ‘Blood conservation with a patient dedicated arterial blood gas analyser’, the new white paper is available for download from Sphere’s online clinical resource centre.

16 Sep 2015

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Benitec Biopharma Limited, a clinical-stage biotechnology company developing innovative therapeutics based on its gene-silencing technology, DNA-directed RNA interference (ddRNAi), is pleased to announce it has initiated a new site for its ongoing Phase 1/2a TT-034 trial at the Methodist Health System Clinical Research Institute in Dallas, Texas.

16 Sep 2015

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Amgen and Xencor, Inc. announced today that the two companies have entered into a research and license agreement to develop and commercialize novel therapeutics in the areas of cancer immunotherapy and inflammation.

16 Sep 2015

Exosomes provide a promising way to induce human stem cell differentiation

Regenerative medicine using stem cells is an increasingly promising approach to treat many types of injury. Transplanted stem cells can differentiate into just about any other kind of cell, including neurons to potentially reconnect a severed spinal cord and repair paralysis.

16 Sep 2015

New Penn Medicine research shows vital role of Esrp1 and Esrp2 genes in skin, organ development

Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.

16 Sep 2015

World Scientific's latest book to be launched on Stem Cell Awareness Day

While the world knows the $3 billion California Institute for Regenerative Medicine sprang from the citizen's initiative, Proposition 71, few people know the struggle required, nor what happened after California said "Yes!"

16 Sep 2015

Scientists find how cells adapt to overcome cancer drugs

CANCER RESEARCH UK scientists have found how cells adapt to overcome cancer drugs designed to interfere with their genetic controls, according to a study published today (Wednesday) in Epigenetics and Chromatin.

16 Sep 2015

USF study shows spleen may be a new target for treating stroke-induced chronic inflammation

Stroke injures the brain, but a new University of South Florida study indicates an abdominal organ that plays a vital role in immune function, the spleen, may be a target for treating stroke-induced chronic inflammation leading to further brain cell death.

16 Sep 2015

Two international business awards won by Aquios CL flow cytometer

Beckman Coulter Life Sciences has gained two prestigious business awards for its clinical flow cytometer, the Aquios CL Flow Cytometer.

From Beckman Coulter Life Sciences - Flow Cytometry 16 Sep 2015

Benefits of reagent reservoirs video

A new short and engaging SimpleShow’ format video from INTEGRA introduces and explains the unique features and benefits of their Multichannel Pipette Reagent Reservoirs.

From INTEGRA Biosciences 16 Sep 2015

Orthocell presents successful ‘cell factory’ data at European Bone and Joint Infection Society

Regenerative medicine company Orthocell Limited is pleased to announce the presentation of its successful ‘cell factory’ data at the European Bone and Joint Infection Society in Estoril Portugal September 2015.

16 Sep 2015

UCSF receives $5 million grant to create online database on all types of cancer

UC San Francisco has received a National Cancer Institute grant of $5 million over the next five years to lead a massive effort to integrate the data from all experimental models across all types of cancer.

16 Sep 2015

Researchers develop 3D bone marrow that produces functional human platelets ex vivo

Researchers funded by the National Institute of Biomedical Imaging and Bioengineering at Tufts University and their collaborators have successfully developed a 3-dimensional (3D) tissue-engineered model of bone marrow that can produce functional human platelets outside the body (ex vivo).

16 Sep 2015

Roflumilast drug could inhibit growth of brain tumor in children

Current drugs may stop working against the most common type of brain tumor in children, medulloblastoma, but the tumor could be targeted in a new way, according to Stanford University scientists.

15 Sep 2015

Key sequence in killer cells captured by Andor revolution microscope

Although much is known of the immune response to antigen-presenting cells, until now the way the body's own killer cells establish an immunological synapse to destroy those target cells has remained unclear. Now, an international research team led by Professor Gillian Griffiths of Cambridge University has resolved the key sequence of events using high-resolution 4D imaging.

15 Sep 2015

T Cell News and Research

Latest T Cell News and Research

Gynaecological cancer still remains a taboo subject

Specific biomarker predicts which HER2-negative breast cancer patients respond to targeted therapy

Tolerability benefits with sunitinib schedule switch

First-line TKI adverse event profile has no bearing on second-line RCC treatment choice

Active surveillance ‘viable option’ for SRM management

Sphere Medical publishes white paper on blood conservation in critical care

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Exosomes provide a promising way to induce human stem cell differentiation

New Penn Medicine research shows vital role of Esrp1 and Esrp2 genes in skin, organ development

World Scientific's latest book to be launched on Stem Cell Awareness Day

Scientists find how cells adapt to overcome cancer drugs

USF study shows spleen may be a new target for treating stroke-induced chronic inflammation

Two international business awards won by Aquios CL flow cytometer

Benefits of reagent reservoirs video

Orthocell presents successful ‘cell factory’ data at European Bone and Joint Infection Society

UCSF receives $5 million grant to create online database on all types of cancer

Researchers develop 3D bone marrow that produces functional human platelets ex vivo

Roflumilast drug could inhibit growth of brain tumor in children

Key sequence in killer cells captured by Andor revolution microscope

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in